These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23770636)

  • 1. A rapid, accurate and robust UHPLC-MS/MS method for quantitative determination of BMS-927711, a CGRP receptor antagonist, in plasma in support of non-clinical toxicokinetic studies.
    Zheng N; Zeng J; Akinsanya B; Buzescu A; Xia YQ; Ly V; Trouba K; Peng Q; Aubry AF; Arnold ME
    J Pharm Biomed Anal; 2013 Sep; 83():237-48. PubMed ID: 23770636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved liquid-liquid extraction with inter-well volume replacement dilution workflow and its application to quantify BMS-927711 in rat dried blood spots by UHPLC-MS/MS.
    Zheng N; Zeng J; Ji QC; Angeles A; Buzescu A; Basdeo S; Aubry AF; Trouba K; Patrone LM; Peng Q; Arnold ME
    J Pharm Biomed Anal; 2014 Feb; 89():240-50. PubMed ID: 24316424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
    Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A UHPLC-MS/MS bioanalytical assay for the determination of BMS-911543, a JAK2 inhibitor, in human plasma.
    Liu J; Yuan L; Liu G; Shen JX; Aubry AF; Arnold ME; Ji QC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 991():85-91. PubMed ID: 25930207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the stability, solubility and extraction challenges in reversed-phase UHPLC-MS/MS bioanalysis of a phosphate drug and its prodrug in blood lysate.
    Yuan L; Basdeo S; Ji QC
    J Pharm Biomed Anal; 2018 Aug; 157():36-43. PubMed ID: 29758468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A validated LC-MS/MS method for the simultaneous determination of BMS-791325, a hepatitis C virus NS5B RNA polymerase inhibitor, and its metabolite in plasma.
    Yuan L; Jiang H; Zheng N; Xia YQ; Ouyang Z; Zeng J; Akinsanya B; Valentine JL; Moehlenkamp JD; Deng Y; Aubry AF; Arnold ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Dec; 973C():1-8. PubMed ID: 25464088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioanalysis of dried saliva spot (DSS) samples using detergent-assisted sample extraction with UHPLC-MS/MS detection.
    Zheng N; Zeng J; Ji QC; Angeles A; Aubry AF; Basdeo S; Buzescu A; Landry IS; Jariwala N; Turley W; Burrell R; Arnold ME
    Anal Chim Acta; 2016 Aug; 934():170-9. PubMed ID: 27506357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly sensitive and selective LC-MS/MS method to quantify asunaprevir, an HCV NS3 protease inhibitor, in human plasma in support of pharmacokinetic studies.
    Kandoussi H; Jiang H; Zeng J; Zheng N; Kadiyala P; Eley T; He B; Garimella T; Demers R; Cojocaru L; Aubry AF; Arnold ME
    J Pharm Biomed Anal; 2016 Feb; 119():145-51. PubMed ID: 26683987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rugged and accurate liquid chromatography-tandem mass spectrometry method for the determination of asunaprevir, an NS3 protease inhibitor, in plasma.
    Yuan L; Jiang H; Ouyang Z; Xia YQ; Zeng J; Peng Q; Lange RW; Deng Y; Arnold ME; Aubry AF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():81-6. PubMed ID: 23435345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a carboxylesterase inhibitor of phenylmethanesulfonyl fluoride to stabilize epothilone D in rat plasma for a validated UHPLC-MS/MS assay.
    Yuan L; Fu Y; Zhang D; Xia YQ; Peng Q; Aubry AF; Arnold ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():60-8. PubMed ID: 25151331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid-liquid extraction of strongly protein bound BMS-299897 from human plasma and cerebrospinal fluid, followed by high-performance liquid chromatography/tandem mass spectrometry.
    Xue YJ; Pursley J; Arnold M
    J Pharm Biomed Anal; 2007 Apr; 43(5):1728-36. PubMed ID: 17204392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rugged and accurate liquid chromatography-tandem mass spectrometry method for quantitative determination of BMS-790052 in plasma.
    Jiang H; Zeng J; Deng Y; Xia YQ; Ouyang Z; Jemal M; Salcedo TW; Arnold ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2064-72. PubMed ID: 21704571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of crizotinib in human and mouse plasma by liquid chromatography electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS).
    Roberts MS; Turner DC; Broniscer A; Stewart CF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():151-7. PubMed ID: 24811158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography-tandem mass spectrometry.
    Patteet L; Maudens KE; Sabbe B; Morrens M; De Doncker M; Neels H
    Clin Chim Acta; 2014 Feb; 429():51-8. PubMed ID: 24291056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of zopiclone and zolpidem in whole blood by liquid-liquid extraction and UHPLC-MS/MS.
    Eliassen E; Kristoffersen L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():72-80. PubMed ID: 25264915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a rapid and sensitive UPLC-MS/MS assay for the quantification of tofacitinib in human plasma.
    Bharwad KD; Shah PA; Shrivastav PS; Singhal P
    Biomed Chromatogr; 2019 Apr; 33(4):e4458. PubMed ID: 30520053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid and sensitive assay to quantify valproyl 1-O-acyl glucuronide in supernatants of sandwich-cultured rat hepatocytes using ultra-high performance liquid chromatography-tandem mass spectrometry.
    Surendradoss J; Szeitz A; Teng XW; Chang TK; Abbott FS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():40-9. PubMed ID: 23827518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of benzodiazepines in ante-mortem and post-mortem whole blood by solid-supported liquid-liquid extraction and UPLC-MS/MS.
    Sauve EN; Langødegård M; Ekeberg D; Øiestad AM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():177-88. PubMed ID: 22119506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of a BMS drug candidate and acyl glucuronide from seven glucuronide positional isomers in rat plasma via high-performance liquid chromatography with tandem mass spectrometric detection.
    Xue YJ; Simmons NJ; Liu J; Unger SE; Anderson DF; Jenkins RG
    Rapid Commun Mass Spectrom; 2006; 20(11):1776-86. PubMed ID: 16676324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of evobrutinib and its metabolite evobrutinib-diol in dog plasma by liquid chromatography combined with electrospray ionization tandem mass spectrometry.
    Yang J; Yu H; Tang Q
    Biomed Chromatogr; 2019 Sep; 33(9):e4575. PubMed ID: 31069837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.